The first batch of DRDO-developed anti-Covid drug 2-DG (2-deoxy-D-glucose) was launched on Monday to treat patients suffering from the deadly disease. The medicine comes in powder form and can be taken with water.
Defence Minister Rajnath Singh and Health Minister Harsh Vardhan released the first batch of the 2-DG, an anti-Covid-19 therapeutic application of the drug developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO) in collaboration with Dr Reddy’s Laboratories (DRL).
The drug which has a tongue twister name — 2-deoxy-D-glucose or 2-DG — was developed by a DRDO lab in collaboration with the Hyderabad-based pharma giant, Dr Reddy’s Laboratories. The Drugs Controller General of India (DCGI), the apex body, has approved the medicine for emergency use
Rajnath Singh handed over the anti-Covid drug to his cabinet colleague Harsh Vardhan who handed over it to Delhi All India Institute of Medical Sciences (AIIMS) director Randeep Guleria.
The medicine comes in powder form and can be taken with water.
(Input: PTI, ANI, IANS)